Recent trends in hepatitis B virus infection in the general Korean population
- PMID: 23864799
- PMCID: PMC3712149
- DOI: 10.3904/kjim.2013.28.4.413
Recent trends in hepatitis B virus infection in the general Korean population
Abstract
Background/aims: Hepatitis B virus (HBV) is the major cause of chronic liver disease in Korea, but viral prevalence has decreased because of hepatitis B vaccination programs. In this study, we investigated longitudinal changes in HBV in fection in the general Korean population.
Methods: HBV surface antigen (hepatitis B surface antigen, HBsAg) seropositivity was assessed from the Korea National Health and Nutrition Examination Survey (I to V). In total, 50,140 subjects were tested for serum HBsAg positivity over a period of 12 years (1998 to 2010).
Results: The prevalence of HBsAg seropositivity decreased over the study period. The rates of HBsAg carriers were 4.61% in 1998, 4.60% in 2001, 3.69% in 2005, 3.01% in 2008, and 2.98% in 2010 (p < 0.0001). The reduction in HBV infection rates was more prominent in younger age groups. Among teenagers (10 to 19 years), the percentage of HBsAg carriers decreased from 2.2% in 1998 to 0.12% in 2010 (p < 0.0001). Among those aged 10 to 39 years, the percentage of HBV infection decreased from 4.72% in 1998 to 2.29% in 2010 (p < 0.0001). However, no decreasing trend in HBsAg positivity was observed among those aged 50 or older (p > 0.05). Neither gender nor socioeconomic status were associated with the decreased prevalence of HBsAg carriers.
Conclusions: HBV infection has decreased in the Korean population since the advent of vaccination programs. However, the decrease is limited to the younger population, and viral persistence remains in the middle-aged and older population.
Keywords: Age groups; Hepatitis B surface antigens; Hepatitis B virus; Korea; Prevalence.
Conflict of interest statement
No potential conflict of interest relevant to this article is reported.
Figures


Comment in
-
Hepatitis B virus infection in South Korea: three decades after universal vaccination.Korean J Intern Med. 2013 Jul;28(4):408-9. doi: 10.3904/kjim.2013.28.4.408. Epub 2013 Jul 1. Korean J Intern Med. 2013. PMID: 23864797 Free PMC article. No abstract available.
References
-
- Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;84:405–419. - PubMed
-
- Maynard JE. Hepatitis B: global importance and need for control. Vaccine. 1990;8(Suppl):S18–S20. - PubMed
-
- Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc. 1995;38:1535–1539.
-
- Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine. 2000;19:1026–1037. - PubMed
-
- Jang KM, Woo SH, Yun DH, et al. Seroepidemiologic survey on type B viral hepatitis in inchon area, Department of Internal Medicine, Inchon Christian Hospital. Korean J Intern Med. 1983;26:1331–1336.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical